Cadrenal Therapeutics, Inc. - Common Stock, par value $0.001 per share (CVKD)

Historical Holders from Q3 2024 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
CVKD on Nasdaq
Shares outstanding
1,783,394
Price per share
$13.83
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
114,193
Total reported value
$1,573,701
% of total 13F portfolios
0%
Share change
+45,846
Value change
+$635,888
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
17
Price from insider filings
$6.97
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cadrenal Therapeutics, Inc. - Common Stock, par value $0.001 per share (CVKD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Pham Quang X 24% $6,315,630 421,042 Quang X. Pham 23 Jan 2025
Havlickova 648 a.s. 4.4% $1,174,365 78,291 Havlickova 648 a.s. 31 Dec 2024
MURPHY JOHN RAYMOND 3% $798,075 53,205 John Raymond Murphy 31 Dec 2024
As of 30 Sep 2025, Cadrenal Therapeutics, Inc. - Common Stock, par value $0.001 per share (CVKD) has 17 institutional shareholders filing 13F forms. They hold 114,193 shares. of 1,783,394 outstanding shares (6.4%) .

Institutional Holders of Cadrenal Therapeutics, Inc. - Common Stock, par value $0.001 per share (CVKD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 114,193 $1,573,701 +$635,888 1,382.95% 17
2025 Q2 68,347 $823,305 -$12,431 1,205% 14
2025 Q1 69,304 $1,221,972 +$961,600 1,763% 13
2024 Q4 14,345 $207,858 +$207,206 1,449.02% 8
2024 Q3 5 $68 +$68 1,360% 1